4.6

CiteScore

2.2

Impact Factor
  • ISSN 1674-8301
  • CN 32-1810/R
Shengfa Ni, Lingxiang Liu, Yongqian Shu. Sequential transcatheter arterial chemoembolization, three-dimensional conformal radiotherapy, and high-intensity focused ultrasound treatment for unresectable hepatocellular carcinoma patients[J]. The Journal of Biomedical Research, 2012, 26(4): 260-267. DOI: 10.7555/JBR.26.20120016
Citation: Shengfa Ni, Lingxiang Liu, Yongqian Shu. Sequential transcatheter arterial chemoembolization, three-dimensional conformal radiotherapy, and high-intensity focused ultrasound treatment for unresectable hepatocellular carcinoma patients[J]. The Journal of Biomedical Research, 2012, 26(4): 260-267. DOI: 10.7555/JBR.26.20120016

Sequential transcatheter arterial chemoembolization, three-dimensional conformal radiotherapy, and high-intensity focused ultrasound treatment for unresectable hepatocellular carcinoma patients

More Information
  • Received Date: February 29, 2012
  • The purpose of this study was to evaluate the outcome of patients with unresectable hepatocellular carcinoma (HCC) treated by sequential therapy of transcatheter arterial chemoembolization (TACE), three-dimensional con-formal radiotherapy (3-DCRT) and high-intensity focused ultrasound (HIFU). From October, 2005 to September, 2010, 120 patients with unresectable HCC received the sequential treatments of several courses of TACE followed in 2-4 weeks by 3-DCRT and then a single session of HIFU with a curative intent. The median tumor irradiation dose was 40 Gy. Tumor response, toxicity and overall survival rate were analyzed. Clinicopathologic factors af-fecting the primary technique effectiveness and overall survival rates were investigated by univariate analysis or multivariate analysis. All 120 HCC patients were followed up by the last follow-up time. Among these patients, hepatic toxicities due to treatment were notable in 9 cases. Gastrointestinal bleeding after the overall treatment occurred in 2 cases, leukopenia of grade III was detected in 1 case, radiation-induced liver disease (RILD) was observed in 2 patients, and first- and second-degree skin burn around the HIFU treatment zone were observed in 2 patients and 1 patient, respectively. Among 120 patients, 23, 83 and 14 cases achieved partial response, stable disease and progressive disease, respectively. The overall survival rates at 1 year, 3 years and 5 years were 70%, 35% and 15%, respectively, with a median survival time of 26 months. Both Child-Pugh liver function grading and radiation dose were determined to be independent predictors for overall survival revealed by the multivariate analysis. It is concluded that the sequential therapy of TACE, 3-DCRT and HIFU is a promising therapeutic regi-men for unresectable HCC.
  • Related Articles

    [1]Vitaly Chasov, Ekaterina Zmievskaya, Irina Ganeeva, Elvina Gilyazova, Damir Davletshin, Maria Filimonova, Aygul Valiullina, Anna Kudriaeva, Emil Bulatov. Systemic lupus erythematosus therapeutic strategy: From immunotherapy to gut microbiota modulation[J]. The Journal of Biomedical Research, 2024, 38(6): 531-546. DOI: 10.7555/JBR.38.20240009
    [2]Wen Zhang, Jiahui Wang, Luyao Yang, Yuyun Shao, Hongjun Peng, Longfeng Jiang, Liang Sheng. Hepatic SIRT6 protects against cholestatic liver disease primarily via inhibiting bile acid synthesis[J]. The Journal of Biomedical Research. DOI: 10.7555/JBR.38.20240172
    [3]Ramendu Hom Chaudhuri. The role of amino acids in skeletal muscle health and sarcopenia: A narrative review[J]. The Journal of Biomedical Research. DOI: 10.7555/JBR.38.20240167
    [4]Gaochen Lu, Quan Wen, Bota Cui, Qianqian Li, Faming Zhang. Washed microbiota transplantation stopped the deterioration of amyotrophic lateral sclerosis: The first case report and narrative review[J]. The Journal of Biomedical Research, 2023, 37(1): 69-76. DOI: 10.7555/JBR.36.20220088
    [5]Zhenxiang Gong, Li Ba, Min Zhang. Dysfunction of the oligodendrocytes in amyotrophic lateral sclerosis[J]. The Journal of Biomedical Research, 2022, 36(5): 336-342. DOI: 10.7555/JBR.36.20220009
    [6]Qiu Jinchun, Guo Hongli, Li Ling, Xu Zeyue, Xu Zejun, Jing Xia, Hu Yahui, Wen Xiaoyi, Chen Feng, Lu Xiaopeng. Valproic acid therapy decreases serum 25-hydroxyvitamin D level in female infants and toddlers with epilepsy— a pilot longitudinal study[J]. The Journal of Biomedical Research, 2021, 35(1): 61-67. DOI: 10.7555/JBR.34.20200057
    [7]Sha Lijun, Zhou Shanshan, Xi Yangyang, Li Rong, Li Xiaonan. The level of bile salt-stimulated lipase in the milk of Chinese women and its association with maternal BMI[J]. The Journal of Biomedical Research, 2020, 34(2): 122-128. DOI: 10.7555/JBR.33.20180107
    [8]Yuan Huang, Peng Quan, Yongwei Wang, Dongsheng Zhang, Mingwan Zhang, Rui Li, Nan Jiang. Host-guest interaction of β-cyclodextrin with isomeric ursolic acid and oleanolic acid: physicochemical characterization and molecular modeling study[J]. The Journal of Biomedical Research, 2017, 31(5): 395-407. DOI: 10.7555/JBR.31.20160073
    [9]Ying Ding, Xuhui Shi, Xuanyu Shuai, Yuemei Xu, Yun Liu, Xiubin Liang, Dong Wei, Dongming Su. Luteolin prevents uric acid-induced pancreatic b-cell dysfunction[J]. The Journal of Biomedical Research, 2014, 28(4): 292-298. DOI: 10.7555/JBR.28.20130170
    [10]Chen Liang, Shiwen Guo, Ling Yang. All-trans retinoic acid upregulates VEGF expression in glioma cells in vitro[J]. The Journal of Biomedical Research, 2013, 27(1): 51-55. DOI: 10.7555/JBR.27.20120048
  • Cited by

    Periodical cited type(4)

    1. De la Cruz-Color L, Dominguez-Rosales JA, Maldonado-González M, et al. Evidence That Peripheral Leptin Resistance in Omental Adipose Tissue and Liver Correlates with MASLD in Humans. Int J Mol Sci, 2024, 25(12): 6420. DOI:10.3390/ijms25126420
    2. Casado ME, Collado-Pérez R, Frago LM, et al. Recent Advances in the Knowledge of the Mechanisms of Leptin Physiology and Actions in Neurological and Metabolic Pathologies. Int J Mol Sci, 2023, 24(2): 1422. DOI:10.3390/ijms24021422
    3. Chenouard V, Remy S, Tesson L, et al. Advances in Genome Editing and Application to the Generation of Genetically Modified Rat Models. Front Genet, 2021, 12: 615491. DOI:10.3389/fgene.2021.615491
    4. Lin SY, Yang CP, Wang YY, et al. Interleukin-4 Improves Metabolic Abnormalities in Leptin-Deficient and High-Fat Diet Mice. Int J Mol Sci, 2020, 21(12): 4451. DOI:10.3390/ijms21124451

    Other cited types(0)

Catalog

    Article Metrics

    Article views (4081) PDF downloads (125) Cited by(4)
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return